Young man works with local organization to help Parkinson's patients
You’re never too young to make a difference. Zachery Hunter has been working with Parkinson’s In Motion, a local 501©(3) ...
Oklahoma woman with Parkinson’s Disease duped out of $20,000 in bitcoin scam
An elderly Oklahoma woman stricken with Parkinson’s Disease lost $20,000 in a cryptocurrency ploy that was crafted as a scam ...
PharmaTimes1h
AC immune announces positive trial results for early Parkinson’s treatment
AC Immune SA has reported encouraging interim results from its phase 2 VacSYn clinical trial of ACI-7104.056, an ...
GlobalData on MSN1d
DMTs are major clinical research focus for Parkinson’s disease, analysis shows
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
Protein variant presents a potential new target for developing effective treatments for Parkinson's disease
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
Make this one lifestyle change to lower your Parkinson’s disease risk
There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.
EurekAlert!2d
Researchers at TAU discovered a potential new target for developing effective treatments for Parkinson's disease
Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...
News Medical on MSN1d
New biomarker could help predict Parkinson’s disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
‘Easy’ way to tackle world’s fastest growing disease
A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...
Researchers identify a potential biomarker of Parkinson's disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
manilatimes2h
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson's Disease Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein ...